Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Isoflavone dietary supplement improves the functioning of the arteries in stroke patients

24.09.2008
A dietary supplement containing isoflavone – a chemical found in soybeans, chickpeas, legumes and clovers – can improve artery function in stroke patients according to new research published online in Europe’s leading cardiology journal, the European Heart Journal [1] today (Wednesday 24 September).

The study is believed to be the first randomised controlled trial to investigate the effects of isoflavone supplement on the way the brachial artery (the main artery in the arm) dilates in response to an increase in blood flow – a phenomenon known as flow-mediated dilation (FMD) – in patients with established cardiovascular disease. Brachial FMD is an indicator of the functioning of the cells that line the inner surfaces of blood vessels (vascular endothelium), and endothelial dysfunction is implicated in cardiovascular disease.

Professor Hung-Fat Tse, William MW Mong Professor in Cardiology and Academic Chief of the Cardiology Division in the Department of Medicine, Queen Mary Hospital, The University of Hong Kong (Hong Kong, China) and his team found that 12 weeks of isoflavone supplement, at a dose of 80 mg a day, significantly improved brachial FMD and, therefore, vascular endothelial dysfunction in patients who had suffered an ischaemic stroke (a stroke caused by blood clots or other obstructions).

“These findings may have important implications for the use of isoflavone for secondary prevention in patients with cardiovascular disease, on top of conventional treatments,” the authors wrote in their EHJ paper.

The trial was a double-blind, placebo-controlled trial, involving 50 patients taking the isoflavone supplement, and 52 taking a placebo pill. The researchers measured FMD by using ultrasound to record the performance of the brachial artery as the blood flow returned to normal after having a pneumatic tourniquet on the forearm inflated and then released. FMD was defined as the percentage change in the brachial artery diameter between its normal size (baseline) and one minute after the tourniquet’s deflation.

Eighty per cent of the patients had an impaired FMD of less than 3.7% at the start of the study, but after 12 weeks of isoflavone or placebo, there was an improvement of one per cent in the isoflavone-treated patients compared with the controls.

Prof Tse explained: “Although the absolute increase in brachial diameter – one per cent – is small, the relative increase actually amounted to about 50% because the mean average FMD in these stroke patients was about two per cent. In fact, in patients with severe endothelial dysfunction, there might not be dilatation of brachial diameter at all.”

In their paper, the authors wrote: “The treatment effect of isoflavone in our study was comparable with lifestyle changes with endurance training or pharmacological interventions with statin therapy.”

In addition, the prevalence of impaired FMD after 12 weeks became significantly lower in isoflavone-treated patients than in the controls (isoflavone: 58%, control: 79%). There was also a greater effect in patients with more severe endothelial dysfunction.

“The patients who had a lower initial FMD were found, in general, to respond with a larger absolute increase in FMD after receiving 12 weeks of isoflavone intervention, compared to patients who had a better baseline FMD in the first place,” said Prof Tse. “These findings suggest that isoflavone reverses endothelial dysfunction in this group of patients with cardiovascular disease. This has important clinical implications, as the benefit of the treatment is conferred to the group of patients with the highest risks for cardiovascular events, and this effect persists, even at this rather late stage of the cardiovascular continuum.”

No improvement from isoflavone treatment was found in diabetic patients compared with non-diabetic patients, but there was an improvement of one per cent in patients who were current smokers or who had smoked in the past compared with non- or never smokers. “Since smoking is known to be associated with more severe endothelial dysfunction, this observation was coherent with our hypothesis that patients with worse baseline endothelial function are, in general, more responsive to isoflavone treatment,” said Prof Tse.

The researchers also found that 12 weeks of isoflavone treatment resulted in a significant decrease in levels of high-sensitivity C-reactive protein. This protein increases during systemic inflammation and is an independent predictor of cardiovascular-related events. “These findings suggested that isoflavone treatment alleviated vascular inflammatory stress and was an important component that mediated the reversal of endothelial dysfunction in this group of patients,” wrote the authors.

Prof Tse said that the mechanisms by which isoflavone produces these changes in FMD were not completely understood. Other than the anti-inflammatory effect observed in this study, isoflavone is a major class of phytoestrogens – naturally occurring chemicals that mimic the effect of the human hormone oestrogen. Oestrogen is known to protect against heart disease and so this could be a possible mechanism.

He said it was too early to make clinical recommendations about the use of isoflavone supplements for stroke patients. “Our study implied that diets with higher isoflavone contents might be beneficial in reducing cardiovascular risk in ischaemic stroke patients. Since atherosclerosis is a generalised process, it might be reasonable to propose that a similar effect be observed in other kinds of CVD. However, specific response from different CVD-related conditions requires further testing. At this juncture, regular isoflavone supplement might not be advocated since the benefits and side effects of long-term supplementation are still unknown.

“A balanced diet is still the top priority in promoting health. Diets with higher soy content might be beneficial due to the isoflavone contents. These food products also, in general, have higher contents of polyunsaturated fats, fibre, vitamins and less saturated fat.”

Prof Tse and his colleagues are continuing with prospective studies of isoflavone to see what effect it has on clinical outcomes such as overall survival and the incidence of cardiovascular events.

[1] Reduction of C-reactive protein with isoflavone supplement reverses endothelial dysfunction in patients with ischaemic stroke. European Heart Journal. doi:10.1093/eurheartj/ehn409

Emma Mason | alfa
Further information:
http://www.escardio.org

More articles from Health and Medicine:

nachricht Millions through license revenues
27.04.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht New High-Performance Center Translational Medical Engineering
26.04.2017 | Fraunhofer ITEM

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Fighting drug resistant tuberculosis – InfectoGnostics meets MYCO-NET² partners in Peru

28.04.2017 | Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

 
Latest News

Wireless power can drive tiny electronic devices in the GI tract

28.04.2017 | Medical Engineering

Ice cave in Transylvania yields window into region's past

28.04.2017 | Earth Sciences

Nose2Brain – Better Therapy for Multiple Sclerosis

28.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>